Will Hologic's Bid for Gen-Probe Spur MDx M&A Activity? | GenomeWeb

NEW YORK (GenomeWeb News) – Following Hologic's $3.7 billion agreement to acquire Gen-Probe, the molecular diagnostics space may be on the verge of some industry consolidation, according to investment analysts.

Yesterday, Hologic announced the $82.75 per-share offer for Gen-Probe, concluding a search Gen-Probe began a year ago for a buyer. The deal has some industry observers considering which other MDx firms may be ripe for a deal.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.